One-year survival of ambulatory patients with end-stage heart failure: the analysis of prognostic factors

被引:16
作者
Szygula-Jurkiewicz, Bozena [1 ,2 ]
Szczurek, Wioletta [3 ]
Skrzypek, Michal [4 ]
Zakliczynski, Michal W. [2 ,5 ]
Siedlecki, Lukasz [2 ]
Przybylowski, Piotr [2 ]
Gasior, Mariusz [1 ,2 ]
Zembala, Marian [2 ,5 ]
机构
[1] Med Univ Silesia, Dept Cardiol 3, Sch Med, Div Dent Zabrze, Katowice, Poland
[2] Silesian Ctr Heart Dis, Zabrze, Poland
[3] Med Univ Silesia, Student Sci Soc, Dept Cardiol 3, Sch Med,Div Dent Zabrze, Katowice, Poland
[4] Med Univ Silesia, Sch Publ Hlth Bytom, Dept Biostat, Katowice, Poland
[5] Med Univ Silesia, Dept Cardiosurg Transplantat Vasc & Endovasc Surg, Sch Med, Div Dent Zabrze, Katowice, Poland
来源
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2017年 / 127卷 / 04期
关键词
heart failure; liver dysfunction; modified Model for End-Stage Liver Disease; risk factors; LIVER-DISEASE SCORE; HEPATIC-DYSFUNCTION; PREDICT SURVIVAL; URIC-ACID; TRANSPLANTATION; MORTALITY; MARKERS; MODEL; VALIDATION; MORBIDITY;
D O I
10.20452/pamw.3975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction An increasing number of ambulatory patients are placed on orthotopic heart transplantation (OHT) waiting lists, which results in an extended waiting time and a higher mortality rate. Objectives The aim of this study was to identify the factors associated with reduced survival during a 1-year follow-up in patients with end-stage heart failure listed for an OHT. Patients and methods We retrospectively analyzed the data of 221 adult patients, who were accepted for OHT in our institution over a 2-year period between 2013 and 2014. Results The mean (SD) age of the patients was 54.7 (9.6) years, and 90.1% of them were male. The mortality rate during the follow-up period was 43.3%. The modified Model for End-Stage Liver Disease (modMELD) score (odds ratio [ OR], 1.70; P < 0.001), as well as the plasma levels of high-sensitivity C-reactive protein (hs-CRP; OR, 1.10; P < 0.01), sodium (OR, 0.74; P < 0.001), and uric acid (UA; OR, 1.003; P < 0.05) were independent factors affecting death. The receiver-operating characteristic (ROC) analysis indicated that a modMELD cut-off of 10 (area under the ROC curve [AUC], 0.868; P < 0.001), hs-CRP cut-off of 5.6 mg/l (AUC, 0.674; P < 0.001), plasma sodium level cut-off of 135 mmol/l (AUC, 0.778; P < 0.001), and a plasma UA cut-off of 488 mu mol/l (AUC, 0.634; P < 0.001) were the most accurate factors affecting death. Conclusions In conclusion, although limited to a single center, our study demonstrated that an elevated modMELD score, incorporating a combination of renal and hepatic laboratory parameters, as well as plasma sodium, UA, and hs-CRP levels at the time of listing are associated with reduced survival in ambulatory patients with end-stage heart failure, accepted for OHT.
引用
收藏
页码:254 / 260
页数:7
相关论文
共 25 条
[1]   Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation [J].
Aaronson, KD ;
Schwartz, JS ;
Chen, TM ;
Wong, KL ;
Goin, JE ;
Mancini, DM .
CIRCULATION, 1997, 95 (12) :2660-2667
[2]   Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J].
Allen, Larry A. ;
Felker, G. Michael ;
Pocock, Stuart ;
McMurray, John J. V. ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
Wang, Duolao ;
Yusuf, Salim ;
Michelson, Eric L. ;
Granger, Christopher B. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (02) :170-177
[3]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[4]   Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure [J].
Bergamini, Corinna ;
Cicoira, Mariantonietta ;
Rossi, Andrea ;
Vassanelli, Corrado .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (05) :444-452
[5]   Hepatic dysfunction and survival after orthotopic heart transplantation: Application of the MELD scoring system for outcome prediction [J].
Chokshi, Aalap ;
Cheema, Faisal H. ;
Schaefle, Kenneth J. ;
Jiang, Jeffrey ;
Collado, Elias ;
Shahzad, Khurram ;
Khawaja, Tuba ;
Farr, Maryjane ;
Takayama, Hiroo ;
Naka, Yoshifumi ;
Mancini, Donna M. ;
Schulze, P. Christian .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (06) :591-600
[6]   The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy [J].
Goda, Ayumi ;
Lund, Lars H. ;
Mancini, Donna .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (03) :315-325
[7]   Albumin levels predict survival in patients with systolic heart failure [J].
Horwich, Tamara B. ;
Kalantar-Zadeh, Kamyar ;
MacLellan, Robb W. ;
Fonarow, Gregg C. .
AMERICAN HEART JOURNAL, 2008, 155 (05) :883-889
[8]   The Cardiorenal Syndrome Do We Need a Change of Strategy or a Change of Tactics? [J].
Jessup, Mariell ;
Costanzo, Maria Rosa .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (07) :597-599
[9]  
Kaplon-Cieslicka A, 2015, POL ARCH MED WEWN, V125, P120
[10]   Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation [J].
Kato, Tomoko S. ;
Stevens, Gerin R. ;
Jiang, Jeffrey ;
Schulze, P. Christian ;
Gukasyan, Natalie ;
Lippel, Matthew ;
Levin, Alison ;
Homma, Shunichi ;
Mancini, Donna ;
Farr, Maryjane .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (03) :333-340